{"id":4009,"date":"2023-02-17T20:16:43","date_gmt":"2023-02-17T20:16:43","guid":{"rendered":"https:\/\/mirm-pitt.net\/technologies\/?post_type=avada_portfolio&p=4009"},"modified":"2023-02-17T20:16:43","modified_gmt":"2023-02-17T20:16:43","slug":"self-regulating-device-for-modulating-inflammation-4","status":"publish","type":"avada_portfolio","link":"https:\/\/mirm-pitt.net\/technologies\/patents\/self-regulating-device-for-modulating-inflammation-4\/","title":{"rendered":"Self-regulating device for modulating inflammation"},"content":{"rendered":"

Self-regulating device for modulating inflammation<\/h1>\n
\n
\n
\n

<\/h2>\n<\/section>\n<\/div>\n<\/div>\n
\n
\n
\n

<\/h2>\n<\/section>\n<\/div>\n<\/div>\n<\/div>
<\/div><\/div><\/div>

Inventors:<\/strong> Yoram Vodovotz: Gregory M. Constantine: Jorg Christian Gerlach MD, PhD: Qi Mi: Maxim Mikheev: David O. Okonkwo: Alexey Solovyev<\/span>
\n<\/strong><\/p>\n

Patent Number:<\/strong> 11,224,685<\/p>\n

\n
\n
\n

Abstract<\/h3>\n
\n
\n
A bioreactor is provided which contains cells capable of producing cytokine inhibitors in response to cytokines, in a manner regulated by the local or systemic milieu of an individual patient and predicted by mechanistic computational simulations. The bioreactor transfers the cytokine inhibitors to a patient in need of control of the inflammation process as part of a disease or condition in the patient, such as sepsis, trauma, traumatic brain injury, or wound healing. Related methods also are provided.<\/div>\n<\/section>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>
<\/div>
<\/div>
<\/div>